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Abstract
Background The development of a functional retinal pros-
thesis for acquired blindness is a great challenge. Rapid
progress in the field over the last 15 years would not have been
possible without extensive animal experimentation pertaining
to device design and fabrication, biocompatibility, stimulation
parameters and functional responses. This paper presents an
overview of in vivo animal research related to retinal
prosthetics, and aims to summarize the relevant studies.
Methods A Pubmed search of the English language literature
was performed. The key search terms were: retinal implant,
retinal prosthesis, artificial vision, rat, rabbit, cat, dog, sheep,
pig, minipig. In addition a manual search was performed based
on references quoted in the articles retrieved through Pubmed.
Results We identified 50 articles relevant to in vivo animal
experimentation directly related to the development of a
retinal implant. The highest number of publications related
to the cat (n=18).
Conclusion The contribution of animal models to the
development of retinal prosthetic devices has been enormous,
and has led to human feasibility studies. Grey areas remain
regarding long-term tissue-implant interactions, biomaterials,
prosthesis design and neural adaptation. Animals will
continue to play a key role in this rapidly evolving field.
Keywords Retinal implant . Retinal prosthesis .
Artificial vision . Animal . Surgery . Blindness
Introduction
The development of a retinal prosthesis in order to restore
functional vision to blind patients is a huge challenge. Multi-
disciplinary research involving engineers, neuroscientists,
cellular biologists and ophthalmologists has led to pilot
human implantations of both epi- and subretinal devices.
The paradigm for this work was established over 15 years ago
by Humayun et al., whose fundamental work showed that in
retinitis pigmentosa (RP) and in age-related macular degen-
eration (ARMD) up to 80% of bipolar cells and up to 30% of
ganglion cells survived [44, 54, 55, 97, 108]. These findings
underlie the rationale for attempts to stimulate surviving
retinal cells in order to restore some functional vision, using
an electrical stimulation device [17, 31, 45, 46, 88, 89, 124].
Other approaches for advanced retinal degeneration
which remain experimental at the present time include
retinal pigment epithelial (RPE) transplantation [10, 63, 64,
85, 104] and photoreceptor (PR) transplantation [7, 14, 37,
65, 109]. Gene therapy is extremely promising; however, its
potential in advanced retinal dystrophy is currently un-
known [1, 8, 15, 47, 77, 83, 110, 111, 115, 118, 123].
Retinal prostheses are devices which receive and process
external visual stimuli and then excite the diseased retina
with these stimuli in order to elicit a functionally effective
visual response. Such devices can be implanted on the
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epiretinal surface or between the RPE and the retina (i.e.
subretinally) [17, 31, 45, 46, 51, 88, 89, 124]. Stimulations
can also be delivered transchoroidally [72, 73]. A few
reports have been published on pilot implantations in
humans [20, 46, 88, 89, 119, 122].
It is still unclear to what degree a prosthetic device will
ultimately be able to provide more than basic functional
visual improvement to blind or poorly-sighted subjects.
Many unanswered questions remain in the fields of implant
design, biomaterials, electrode fabrication, packaging,
surgical techniques, long-term effects and efficacy. The
degenerating retina undergoes extensive and complex
remodelling [67]. The consequences and implications of
these processes on cell-electrode interactions, and therefore
on electrically generated visual percepts, remain poorly
understood. Animal models provide unique opportunities
for progress in these fields. This paper discusses the animal
models used in retinal prosthesis research, based on a
literature review of published papers in English.
Material and methods
A Pubmed search of the English-language literature was
performed. The key search terms were: retinal implant, retinal
prosthesis, artificial vision, rat, rabbit, cat, dog, sheep, pig,
minipig. In addition, a manual search was performed based on
referenced articles quoted in the articles. Ex vivo studies (for
example eye cup preparations) and early acute retinal
stimulation studies were not considered for this review.
Results
We found 50 articles in the literature relevant to in vivo animal
experimentation in relation to the development of a retinal
prosthesis. The species involved include rats (n=6) [26, 29, 76,
80, 81, 96], rabbits (n=14) [33, 36, 42, 72, 73, 90, 94, 95, 102,
103, 105, 106, 116, 121], cats (n=18) [18, 19, 21–23, 30, 32,
43, 78, 79, 82, 93, 98, 99, 101, 114, 117, 120], dogs (n=4)
[16, 39, 40, 66], sheep (n=1) [51] and pigs/minipigs (n=9)
[34, 42, 49, 59, 69, 91, 92, 100, 102]. Two papers [16, 26]
which involved three animal species do not figure in Table 2
due to lack of space, but are discussed in the review.
Table 1 summarizes the main anatomical characteristics
of these animals
Table 2 lists the species and studies (including study
design) in which they were used.
Rat
The rat is a popular small mammal model of RP, with three
common strains: Royal College of Surgeons (RCS), P23H and
S334ter transgenic lines. The etiology and clinical course of
photoreceptor degeneration differ between these lines [28, 60].
Despite the widespread use of this animal model in non-
surgical treatment strategies of RP and AMD and despite its
low cost and easy availability, its use in prosthetic vision
research has been limited to six studies with subretinal
implants. These studies assessed long-term safety and efficacy
of retinal stimulation [96], local tissue reactions to the implant
and surgical procedure [76, 80, 81], and characteristics of
electrically induced retinal damage [26], as well as the ability
to record activation of the retinotectal pathway [29]. Results
of these studies are summarized in Table 2.
Although the rat eye provides a biological environment
broadly comparable to that of patients with inherited
photoreceptor dystrophies, it obviously differs considerably
from the human eye in terms of size and structure (Table 1).
Although it has the basic features of all mammalian eyes,
its axial length is roughly three times shorter than in
humans, and the lens is proportionately much larger. The
inner retinal blood supply is holangiotic, i.e. supplied by
the central or cilioretinal arteries, as in most mammals.
There is no fovea. Given the size of the rat globe and lens,
an ‘ab interno’ approach to the subretinal space via a
retinotomy and a vitrectomy procedure is not possible. For
that reason, ‘ab externo’ approaches to the subretinal space
have been used [29, 76, 78, 80, 81, 96]. Implantation is
performed by transclerally injecting either basic salt
solution (BSS) or a viscoelastic (e.g. hyaluronic acid,
Healon®) under the retina. This procedure is performed
‘blind’, and insertion into the subretinal space cannot be
controlled peroperatively.
The rat is a useful model for implant research with regard
to histology, biocompatibility and impedance studies. More
complex studies are limited by the small eye size.
Rabbit
The rabbit is an excellent model for wound-healing studies.
The conjunctiva shows an aggressive wound-healing
response, and as a result the rabbit has been used
extensively in glaucoma research [2, 27, 38, 50, 52, 53,
57, 70, 107]. It is also an established model in proliferative
vitreoretinopathy research [13, 24, 25, 27, 48, 52, 53, 62,
86, 112]. It is relatively cheap and easily available.
The rabbit globe is significantly smaller than in humans,
and there is no macula as such but an area centralis with
‘visual streaks’ [56]. Furthermore, there is no dual retinal
circulation, and it is therefore the only model in retinal
prosthetics research with a merangiotic retinal circulation.
Preliminary studies have indicated that the rabbit visual
system can be activated by subretinal [17], epiretinal [71]
and episcleral [105, 106] electrical stimulation. These
paradigms have been explored by several research teams
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Table 2 Overview of publications on retinal implant research using animal models
Palanker
et al.
2004
Pardue
et al.
2005
Pardue
et al.
2005
De
Marco et
al. 2007
Salzmann
et al.
2006
Walter
et al.
1999
Schwahn
et al.
2001
Hämmerle
et al.
2002
Gekeler
2004
Rizzo
et al.
2004
Sakaguchi
et al.
2004
Nakauchi
et al.
2005
Animal model Rat ■ ■ ■ ■ ■
Rabbit ■ ■ ■ ■ ■ ■ ■
Cat
Dog
Sheep
Minipig
Pig
N (eyes) 5 22 26 19 26 10 10 n/a 10 43 5 6
Implant type Epiretinal ▲ ▲
Subretinal ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲
suprachoroidal ▲
Episcleral
Lens lens-sparing ● ● ● ● ● ● ● ● ● ● ● ●
Lensectomy
phacoemulsification
Vitrectomy
mode
no vitrectomy ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙
pars plana
vitrectomy
◙
trans-corneal
vitrectomy
Implantation
mode
trans-scleral/trans-
choroidal
♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦
ab interno (with
vitrectomy)
♦ ♦
trans-corneal
Research aims Surgical safety/
feasability
► ► ► ► ►
biocompatibility ► ► ►
threshold current ► ► ► ►
electrically evoked
cortical recording
► ► ► ► ► ► ►
ERG recording ► ► ► ►
impedance
measurements
►
Optical imaging of
visual cortex
estimation of
perceptual
resolution
OCT and/or FA ► ►
histology ► ► ► ► ► ► ► ► ► ►
immunochemistry
thermal effects of
IR irradiation
Follow up (fu)
in months
5–9d 4,5 1,5 3 2 6 no fu <14 no fu no fu no fu no fu
d: days, ERG: electro-retinogram, FA: fluorescein angiography, h: hours, IR: infrared, n/a: not available, OCT: optical coherence tomography
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Yamauchi
et al.
2005
Shah
et al.
2006
Gerding
et al.
2007
Sailer
et al.
2007
Nakauchi
et al.
2007
Siu &
Morley
2008
Siu &
Morley
2008
Völker
et al.
2004
Eckhorn
et al.
2006
Walter
et al.
2005
Chowdhury
et al. 2005
Chowdhury
et al. 2005
Animal model Rat
Rabbit ■ ■ ■ ■ ■ ■ ■
Cat ■ ■ ■ ■ ■
Dog
Sheep
Minipig
Pig
N (eyes) 9 13 2 18 18 4 4 3 13 3 9 6
Implant type Epiretinal ▲ ▲ ▲ ▲
Subretinal ▲ ▲ ▲ ▲
suprachoroidal ▲ ▲
Episcleral ▲ ▲ ▲ ▲
Lens lens-sparing ● ● ● ● ● ● ● ● ● ●
Lensectomy ●
phacoemulsification ● ●
Vitrectomy
mode
no vitrectomy ◙ ◙ ◙ ◙ ◙ ◙ ◙
pars plana
vitrectomy
◙ ◙ ◙ ◙
trans-corneal
vitrectomy
◙ ◙
Implantation
mode
trans-scleral/trans-
choroidal
♦ ♦ ♦ ♦ ♦ ♦ ♦
ab interno (with
vitrectomy)
♦ ♦ ♦ ♦
trans-corneal ♦
Research aims Surgical safety/
feasability
► ► ► ► ►
biocompatibility ► ►
threshold current ► ► ►
electrically evoked
cortical recording
► ► ► ► ► ►
ERG recording ► ► ► ►
impedance
measurements
Optical imaging of
visual cortex
► ►
estimation of
perceptual
resolution
►
OCT and/or FA ► ►
histology ► ► ► ► ►
immunochemistry ►
thermal effects of
IR irradiation
►
Follow up (fu)
in months
no fu n/a 6–9 no fu no fu 7d no fu 0–15 n/a no fu no fu no fu
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Chowdhury
et al. 2005
Chow
et al.
2001
Chow
et al.
2002
Pardue
et al.
2001
Pardue
et al.
2001
Pardue
et al.
2006
Wilms &
Eckhorn
2005
Eger
et al.
2005
Schanze
et al.
2002
Schanze
et al.
2003
Sachs
et al.
2005
Schanze
et al.
2007
Hesse
et al.
2000
Majjii
et al.
1999
Animal model Rat
Rabbit
Cat ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■
Dog ■
Sheep
Minipig
Pig
N (eyes) 3 19 n/a 21 9 3 4 5 7 3 3 3 4 4
Implant type Epiretinal ▲ ▲ ▲ ▲ ▲ ▲ ▲
Subretinal ▲ ▲ ▲ ▲ ▲ ▲
suprachoroidal
Episcleral ▲
Lens lens-sparing ● ● ● ● ● ● ● ● ● ● ● ●
Lensectomy ● ●
phacoemulsification ●
Vitrectomy
mode
no vitrectomy ◙ ◙ ◙ ◙ ◙
pars plana
vitrectomy
◙ ◙ ◙ ◙ ◙ ◙ ◙
trans-corneal
vitrectomy
◙ ◙ ◙
Implantation
mode
trans-scleral/trans-
choroidal
♦ ♦ ♦ ♦ ♦
ab interno (with
vitrectomy)
♦ ♦ ♦ ♦ ♦ ♦ ♦
trans-corneal ♦ ♦ ♦
Research aims Surgical safety/
feasability
► ► ►
biocompatibility ► ► ► ► ► ►
threshold current
electrically evoked
cortical recording
► ► ► ► ► ► ► ► ►
ERG recording ► ► ► ► ► ►
impedance
measurements
Optical imaging of
visual cortex
estimation of
perceptual
resolution
► ► ►
OCT and/or FA ►
histology ► ► ►
immunochemistry ► ►
thermal effects of
IR irradiation
Follow up (fu)
in months
no fu 10–27 <12 n/a 6–11 36–60 no fu no fu no fu no fu 12h 3 0.5 2–6
Table 2 (continued)
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Güven
et al.
2005
Güven
et al.
2006
Kerdraon
et al.
2002
Schwahn
et al.
2001
Hämmerle
et al.
2002
Laube
et al.
2003
Sachs
et al.
2005
Montezuma
et al. 2006
Schanze
et al.
2006
Sachs
et al.
2005
Gekeler
et al.
2007
Johnson
et al.
2007
Animal model Rat
Rabbit
Cat
Dog ■ ■
Sheep ■
Minipig ■ ■ ■ ■ ■
Pig ■ ■ ■ ■
N (eyes) 5 4 1 6 n/a 3 5 28 8 8 11 n/a
Implant type Epiretinal ▲ ▲ ▲ ▲ ▲
Subretinal ▲ ▲ ▲ ▲ ▲ ▲
suprachoroidal
Episcleral
Lens lens-sparing ● ● ● ● ● ● ● ●
Lensectomy ● ● ● ● ●
phacoemulsification
Vitrectomy
mode
no vitrectomy
pars plana
vitrectomy
◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙ ◙
trans-corneal
vitrectomy
Implantation
mode
trans-scleral/trans-
choroidal
♦ ♦ ♦
ab interno (with
vitrectomy)
♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦
trans-corneal
Research aims Surgical safety/
feasability
► ► ► ►
biocompatibility ► ► ► ► ►
threshold current ► ► ►
electrically evoked
cortical recording
► ► ► ► ►
ERG recording ► ► ►
impedance
measurements
►
Optical imaging of
visual cortex
estimation of
perceptual
resolution
OCT and/or FA ► ► ► ► ►
histology ► ► ► ► ►
immunochemistry ►
thermal effects of
IR irradiation
Follow up (fu)
in months
6–13 2–6 no fu <14 <14 <18 no fu 3 10h 10h 1 no fu
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in order to test/record surgical feasibility of retinal implants
[33, 36, 72, 116], their long-term biocompatibility [36, 42,
72, 102, 116], electrically evoked cortical potentials (EEP)
[33, 73, 90, 95, 121, 105, 106], depth of retinal neuronal
activation [103], and the effect of infrared irradiation on an
implanted infrared receiver [94]. Morley and co-workers
performed episcleral stimulation on two models of retinal
degeneration in the rabbit: the albino rabbit with retinal
ganglion cell (RGC) deficits[106], and the pharmacotoxic
model of selective RPE and photoreceptor degeneration
secondary to systemic administration of sodium iodate
(NaIO3) or monoiodoacetic acid [105]. These studies are
summarized in Table 2.
Cat
Feline and human eyes are almost comparable with regard
to size. The feline eye is slightly smaller and, possessing
both a retinal and a choroidal circulation, is closer to the
human than to the rabbit eye.
Pars plana vitrectomy is more difficult in the cat than in
humans because of the large anterior segment and deep orbit.
The lens volume makes up 10% of the total volume of the
globe—compared to 2.5–3.8% in humans. Whereas an
anterior transcorneal approach has been used by some, others
have opted for a temporal approach, performing a lateral
canthotomy [93] or removing the frontal process of the
zygomatic bone, allowing access to the temporal sclera [18].
Whereas in the human eye vitrectomy and instrumental
manipulation can be safely performed through the pars
plana, the same approach in the cat is likely to cause severe
bleeding or retinal detachment when instruments are
inserted through sclerotomies. As a result, corneal access
sites have been advocated [117]. Lensectomy and subse-
quent air injection into the anterior chamber have been
reported to provide excellent visualisation of the posterior
segment and to allow a more anterior access for instrument
insertion through the corneal incisions [43]. Because of the
high reflectivity of the tapetum lucidum no endoillumina-
tion is necessary, making two-port vitrectomy possible
[114]. It may not be necessary to perform the hazardous
step of posterior hyaloid face detachment in order to obtain
a posterior vitreous detachment [114]. As in the rat,
subretinal viscoelastics have been used to obtain a
subretinal bleb through which to insert an implant [114].
Epiretinal device fixation using a retinal tack is thought to
be unsafe in the cat, given the marked thinning of the
posterior sclera [43].
Notwithstanding the particularly hazardous features of
vitreoretinal surgery in the cat, it has been the most
commonly used animal model in the development of visual
prosthesis so far. We identified 18 studies. The cat model
has been used to test the feasibility [18, 21–23, 93, 117],
biocompatibility [18, 19, 79, 82, 101, 114] and functioning
of specific devices or electrodes [18, 19, 21–23, 30, 32, 43,
78, 82, 93, 98, 99, 101, 117, 120]. Because of the well-
established cortical recording techniques and the good
understanding of the feline visual system, this model has
been largely used in testing cortical representation of
electrical retinal stimulation with cortical electrode record-
ings [18, 19, 21–23, 30, 32, 43, 58, 79, 82, 93, 98, 99, 114,
117, 120, 101](Table 2).
The Abyssinian cat has a very high prevalence of a slow
rod-cone dystrophy, akin to Leber’s congenital amaurosis.
The mutation has recently been identified [68]. These cats,
however, are not readily available commercially.
Dogs’ and cats’ eyes are very similar in structure, size,
lens size, presence of a tapetum, holangiotic retinal
circulation, and distinct, characterized retinal dystrophies
(see Table 1). Retinal dystrophy in the Irish setter (RCD1
mutation) has been studied for over 20 years [3–5, 12, 87].
Retinal stimulation studies have been successfully con-
ducted with this model [16, 39, 40, 66]. The Briard beagle
carries a well-characterized retinal dystrophy [6, 113].
These dogs were famously used in the first effective viral
transfection gene therapy trial for blindness [1]. Dogs are
expensive to house, in particular because the retinal
degeneration takes several months to develop (in RCD1
dogs, the ERG extinguishes at approximately 18 weeks)
[66]. We found three canine studies in which implant-
biocompatibility and biostability [39, 40, 66] and one study
in which electrically elicited responses (EERs) produced by
epiretinal stimulation [16] were examined.
Sheep
The ovine eye shows important differences relative to the
human eye: it is approximately 30% larger and photore-
ceptor populations and distribution are different; there is a
retinal tapetum; iris muscle orientation, ciliary body and
muscle location differ from the human eye. There is no
anterior ciliary artery communication with the major arterial
circle of the iris [75]. We found only one study using the
ovine model in retinal implant research [51] (see Table 2).
The use of the sheep was justified on the grounds that the
ovine ocular dimensions are larger than in humans, and that
notwithstanding these differences there are many similari-
ties between the sheep and the human eye.
Pig/minipig
A strain of transgenic pig with a rhodopsin mutation has
been described and studied [61, 84], but is not commer-
cially available.
The porcine ocular structure is close to that of humans,
especially with regard to size, cone distribution and retinal
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layers, with an area centralis comparable to the human
macula [61]. The retinal circulation is holangiotic; this is
relevant in post-implantation vascularization studies. Sev-
eral anatomical differences to the human do exist: medially,
there is a cartilaginous nictitating membrane which can be
bothersome during and after surgery. This membrane is
present in other animals such as the cat, but it is less
developed. In addition to the six extraocular muscles
similar to those in the human, pigs also have a powerful
muscle surrounding the optic nerve and the blood vessels
(m. retractor bulbi), which tends to retract the globe into the
orbit, making surgical access difficult. For adequate access,
it is thus necessary to paralyze the extraocular muscles
peroperatively (curarisation); this may prove hazardous,
especially as some strains of minipig do not respond well to
general anesthesia. Other features include a vigorous
inflammatory response to intraocular surgery—particularly
involving the crystalline lens—and diffuse choroidal bleed-
ing, which can be unstoppable [34].
Compared to smaller mammals, housing and breeding
costs are significant. Furthermore, as Schanze and colleagues
point out, there is much less accumulated knowledge about
the visual system of pigs relative to that of cats [100].
Notwithstanding these limitations, minipigs and pigs have
featured extensively in prosthesis research. Published studies
include feasibility/safety of implant procedures [34, 92],
control of retinal-implant contact using impedance measure-
ments [49], long-term biocompatibility [42, 59, 69, 102],
physiological effects of the implants using epidural record-
ings of evoked cortical potentials [59, 91, 92, 100, 102] and
behavioural reactions to electrical stimulation [34].
Discussion
Given the uncertainty of long-term implant behaviour with
regard to electronics, packaging, biotolerance, stimulation
parameters and functional outcomes, further studies are
evidently necessary.
A number of groups world-wide are developing and
testing epi- and subretinal implants in humans. The most
advanced project is the Argus I (Second Sight, Sylmar, CA,
USA) 16-electrode epiretinal implant feasibility study [45],
which demonstrated an effective camera system for image
acquisition, wireless transmission to ocular components,
array-retina stimulation and documented functional improve-
ments, notably with regard to mobility, over a 3-year
period in six subjects. A follow-up study with a 60-electrode
(Argus II) device is currently underway world-wide. There
are no published reports to date of other successful, long-term
implantations.
It is still unclear, though, which approach (epiretinal,
subretinal, episcleral or transchoroidal) will ultimately
provide the best functional outcomes. In view of the invasive
and complex surgery required, potential risks to the eye and
unclear long-term effects, investigators wishing to implant
experimental devices in humans face hard questions from
their local institutional ethics committees, as well as from
their medical device accreditation authorities.
With the exception of one historic pilot study on acute
electrical stimulation [74] we found no published papers on
retinal implants in non-human primates. In vivo pilot
studies in primates with so-called ‘minimally invasive’
trans-scleral spike electrodes have indeed been reported in
meetings , but no peer-reviewed articles on this subject
have been published [35]. At this stage, there is no evidence
that primates can provide better data than cats, rabbits dogs
or pigs in retinal implant development. Given the traumatic
nature of these experiments, and the scope for further
experimentation in lower-order mammals, we believe
primate studies are ethically questionable at the present
time. This contrasts with pilot experiments using electrode
array stimulation of the visual cortex [11], in which the
psychophysical capabilities of the primates are essential.
Reports from feasibility studies in humans from the
Doheny group with the Second Sight Argus I 16-electrode
epiretinal implant [119, 122] have shown that it is safe, in
certain circumstances, to make the leap to human implan-
tation. However, the fact remains that new devices mandate
extensive pre-clinical investigation. There are cogent
theoretical reasons for advocating subretinal placement,
however challenging this proves to be in practice. Animal
experimentation in this field remains inescapable, notwith-
standing the major limitations of psychophysical testing in
animals. In addition, as highlighted by Hafezi et al. in an
historical review on animal models for retinal degenerations
and dystrophies, there are few ‘non-mouse’ models for
retinal degeneration [41].
Not all studies mentioned above fit the categorization by
species. For example, Chen et al. [16] studied electrically
evoked potentials in mice, dogs and humans following
epiretinal stimulation. Although rare, multi-species studies
are useful as they provide information on how various
models respond to broadly similar stimuli.
Although animal electrophysiological test protocols are
well established [18, 19, 21–23, 30, 32, 34, 43, 58, 59, 79,
82, 91–93, 98–100, 102, 114, 117, 120], such testing in
lower-order mammals is very difficult. In vivo electrical
stimulations in the rat at both corneal and RGC levels were
successfully reported by Baig-Silva et al. [9], highlighting
wide variations in thresholds and charge densities between
acute and chronic stimulation experiments.
Small mammals such as the rat are cheap and easy to
obtain. Rat strains with RP-like retinal degenerations are
commercially available, but their usefulness in prosthesis
development is limited by anatomical constraints. Larger
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mammals provide a closer model to the human eye, but there
are no commercially available RP-like models. Compromises
are therefore inevitable. Due to the close similarities between
human and porcine eyes in terms of functional anatomy, and
given considerations of cost and availability, the pig/minipig
appears to be a useful model in retinal implant research.
In conclusion, animal models are essential in the
ongoing development of retinal prosthetics. Since psycho-
physical testing is paramount in assessing the functional
effects of an implanted device, feasibility studies in humans
are admissible once the functionality of a new design has
been established in an animal model. The use of primates
does not appear justified at the present time.
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